Science

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Science
Jun 2, 2025, 14:49 | Science
Jean-Charles Soria: Carcinoma of Unknown Primary
Jean-Charles Soria, Amgen's senior vice president of Oncology within Global Development, shared an article on LinkedIn:…
Jun 2, 2025, 10:46 | Science
The Silent Epidemic: Understanding How Non-Communicable Diseases in Tanzania are Reshaping Our Lives
New Article Explores the Rising Impact of Non-Communicable Diseases in Tanzania Titled "The Silent Epidemic:…
Jun 2, 2025, 09:10 | Science
The Institute of Cancer Research Announces FDA Approval of First Therapy for Low-Grade Serous Ovarian Cancer
The Institute of Cancer Research shared a post on LinkedIn: "NEW: The FDA has granted…
Jun 2, 2025, 09:07 | Science
PSOGI Highlights CAIRO-6 Trial Outcomes on HIPEC and Chemotherapy in Colorectal Peritoneal Metastases
Peritoneal Surface Oncology Group International (PSOGI) shared a post on LinkedIn: "Congratulations to the investigators…
Jun 2, 2025, 08:57 | Science
Chris De Savi: New Winning Drugs in ER+ Breast Cancer
Chris De Savi, Chief Scientific Officer, Partner at Curie.Bio posted on LinkedIn: "New Winning Drugs…
Jun 2, 2025, 06:09 | Science
Gerard Mawhinney: 14-year review of the Oxford Spinal Sarcoma Service on primary spinal tumour care
Gerard Mawhinney, DPhil Student at Clinical Neurosciences, Nuffield Department of Clinical Neurosciences, University of Oxford,…
Jun 2, 2025, 05:32 | Science
ALNEO Phase II Trial Highlights Promising Role of Perioperative Alectinib in Stage III Resectable ALK-Positive NSCLC
At ASCO 2025, Dr. Alessandro Leonetti and colleagues from the Italian GOIRC consortium presented final…
Jun 2, 2025, 05:14 | Science
SAVANNAH Trial Highlights Synergistic Effect of Savolitinib and Osimertinib in EGFR-Mutant NSCLC with MET-Mediated Resistance
At ASCO 2025, Dr. Benjamin P. Levy and an international team of investigators presented new…
Jun 2, 2025, 04:58 | Science
NATALEE Trial Subgroup Analysis Confirms Ribociclib Benefit Across Age and Menopausal Status in High-Risk HR+/HER2− Early Breast Cancer
At ASCO Breast Cancer Congress 2025, Dr. Kevin Kalinsky and an international team of investigators…
Jun 2, 2025, 04:38 | Science
T-DXd Demonstrates Promising Activity in Desmoplastic Small Round Cell Tumor (DSRCT)
At ASCO 2025, Dr. Emily K. Slotkin and colleagues from Memorial Sloan Kettering Cancer Center…
All: 1522 Posts: 61 - 70
Special Coverage